Pain Patch Market to Grow with a CAGR of 4.76% through 2030
Rising prevalence of chronic pain and growing aging
population are factors driving the global Pain Patch market in the forecast
period 2026-2030.
According to TechSci Research report, “Pain Patch
Market – Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2030”, the Global Pain Patch Market was valued at USD 5.12 Billion
in 2024 and is expected to reach USD 6.78 Billion by 2030 with a CAGR of 4.76% during
the forecast period. The global pain patch market has been experiencing
significant growth in recent years, and this trend is expected to continue in
the foreseeable future. Pain patches, also known as transdermal patches, offer
a convenient and non-invasive method for managing various types of pain.
The global
population is aging, with a growing number of elderly individuals. With age
often comes a higher likelihood of developing chronic health conditions that
cause pain. Pain patches are especially beneficial for older adults who may
have difficulty swallowing pills or managing multiple medications. This
demographic shift is expected to boost the demand for pain patches
significantly. Recent advancements in drug delivery
technology have led to the development of more efficient and sophisticated pain
patch formulations. These patches can deliver a wide range of medications,
including opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and muscle
relaxants, with improved precision and consistency. As technology continues to
evolve, pain patches are becoming increasingly customizable and effective.
Consumers are increasingly seeking
non-invasive and convenient treatment options for pain management. Pain patches
offer a discreet and hassle-free alternative to traditional pain relief
methods, such as oral medications or injections. This preference for
non-invasive treatments is driving the adoption of pain patches, particularly
among those who wish to avoid the side effects associated with oral
medications. The use of pain patches has gained popularity in the field
of sports medicine. Athletes often deal with acute injuries and muscle
soreness, and pain patches provide a localized and efficient way to manage pain
without affecting their performance. As the importance of sports medicine
continues to grow, so does the demand for pain patches in this sector. The
pharmaceutical industry's commitment to research and development has resulted
in the approval of new pain patch formulations by regulatory agencies such as
the FDA. Additionally, ongoing clinical studies are providing valuable data on
the safety and efficacy of pain patches, instilling confidence in both healthcare
providers and patients. The Global Pain Patch Market is segmented into product
type, type, distribution channel and company.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Pain Patch Market”
The Global Pain Patch Market is
segmented into product type, type, distribution channel, regional distribution, and
company.
Based on product type, Non-Opioid Patches are expected to remain the fastest-growing segment in the global Pain Patch market. These patches have seen significant advancements in recent years, making them a preferred choice for both patients and healthcare providers. By using transdermal delivery systems, non-opioid pain patches provide controlled and sustained pain relief over time, reducing the need for frequent dosing. Manufacturers are now offering customized formulations to target different types of pain, such as neuropathic, musculoskeletal, and inflammatory pain, enhancing their overall effectiveness. Additionally, non-opioid pain patches tend to have fewer side effects compared to oral medications, which is especially beneficial for patients sensitive to the gastrointestinal or central nervous system side effects of opioids or NSAIDs. This combination of targeted relief and minimal side effects is driving rapid growth in this segment..
Based on region, second dominating region in the global
pain patch market was Europe. The European market for pain
patches is experiencing significant growth driven by factors such as an
increasing aging population, the prevalence of chronic pain conditions, and
growing consumer awareness regarding pain management solutions. The region's
healthcare systems are well-established, and there is a strong preference for
non-invasive, easy-to-use pain relief options, which makes pain patches a
popular choice among consumers.
One of the key drivers for the growth of
the pain patch market in Europe is the region's aging population. As people
age, they become more susceptible to chronic pain conditions, such as
osteoarthritis, back pain, and muscle pain, all of which can significantly
impact quality of life. The increasing number of elderly individuals in
European countries is contributing to the rising demand for effective and
convenient pain relief methods like topical pain patches. These patches provide
localized pain relief without the need for oral medication, making them an
appealing choice for older individuals who may be more prone to side effects
from systemic medications. Additionally, the increasing awareness of the
benefits of non-pharmaceutical treatments for pain management is contributing
to the rising adoption of pain patches in Europe. Many consumers are shifting
towards non-invasive pain relief options, including over-the-counter products
like pain patches, which are seen as safer alternatives to oral pain
medications. As healthcare professionals and patients alike seek alternatives
to traditional pain management methods, the demand for pain patches is steadily
increasing.
Major companies operating in Global Pain Patch Market
are:
- NEXGEL Inc.
- Viatris Inc.
- Johnson and
Johnson
- Teva
Pharmaceutical Industries Ltd.
- Sorrento
Therapeutics Inc.
- Hisamitsu Pharmaceutical
Co., Inc.
- Endo,
Inc.
- Purdue Pharma
L.P.
- Amneal
Pharmaceuticals LLC
- Grünenthal
GmbH
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The global pain patch market is poised
for significant growth in the coming years, driven by increasing demand for
non-invasive, effective pain management solutions. As the global population
ages, with a rising incidence of chronic pain conditions, the demand for pain
patches is expected to surge. Innovations in drug delivery systems, including
patches offering targeted and sustained relief, will further fuel market
expansion. Additionally, growing consumer preference for over-the-counter,
easy-to-use, and localized pain treatments will support this growth. The market
will also benefit from advancements in personalized healthcare and regulatory
improvements that ensure safety and efficacy. As a result, the global pain
patch market is set to experience sustained momentum, with expanding
opportunities across key regions such as North America, Europe, and Asia
Pacific”, said Mr. Karan
Chechi, Research Director of TechSci Research, a research-based management
consulting firm.
“Pain Patch Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type
(Non-Opioid Patches, Opioid Patches), By Type (Prescription Medicines, OTC
Medicines), By Distribution Channel (Hospital Pharmacies, Drug Stores and
Retail Pharmacies, Online Providers), By
Region and Competition, 2020-2030F”, has evaluated
the future growth potential of Global Pain Patch Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Pain Patch Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com